All Covid-19 updates and resources can be found here: COVID-19 INFORMATION FOR CF COMMUNITY
Skip To Content
Volunteer Advocate
cf insights cf insights
Trikafta is coming to Quebec

Special CF Canada Bulletin: Trikafta is coming to Quebec!

Another domino falls! Quebec will soon begin funding Trikafta on their public drug program, RAMQ. We learned today that Quebec is joining Alberta, Ontario and Saskatchewan in being among the first provinces to bring this transformational drug to people living with cystic fibrosis in Canada.

Cystic Fibrosis Canada and the CF community in Quebec have fought hard for this moment and we are very pleased that this life-changing drug is finally making it into the hands of Quebecers with cystic fibrosis.

Cystic Fibrosis Canada continues to call upon all provinces to move quickly to add Trikafta to their public drug plans for everyone who can benefit from it. Please stay tuned as we will bring you actions in the coming weeks that you can take to help keep the pressure on these lagging decision makers.

When will access start?

It is our understanding that funding for Trikafta will start this Wednesday, September 29th. Due to the drug system in Quebec, this would mean that, as of Wednesday, Trikafta will be covered by both public and private insurers in Quebec.

Did they mention access criteria?

From an initial glance, it appears that Quebec has kept the same access criteria as what was released in the INESSS recommendation shared on September 2nd. However, patients with a lung function over 90% may have the opportunity to access Trikafta through the “patient d’exception” program, on a case-by-case basis.

We will continue to review the criteria released by the Government of Quebec and will update our website with more information as soon as possible.

You can also follow our Division Quebec Facebook Page and Instagram account for local updates as we learn more.

No One Left Behind

We are so pleased to celebrate this news with Quebecers living with cystic fibrosis. But we do not lose sight of those left out.. There are still too many people waiting for access to Trikafta in Canada. Cystic Fibrosis Canada will keep going further in advocacy and in CF research until every Canadian living with cystic fibrosis can have a day to celebrate and look forward to a longer, healthier future.

For those who have lost loved ones to CF and for whom this news comes too late, you are in our thoughts today and always.

Join us Live today

We’ll be going live, in French, on Cystic Fibrosis Canada’s Quebec Region Facebook Page today at 3pm EDT. Join Dr John Wallenburg, Cystic Fibrosis Canada’s Chief Scientific Officer and Pascal Chouinard, a government relations specialist from Hill+Knowlton and Cateryne Rhéaume, National Bilingual Communications and Marketing Associate to share your reactions to today’s news and find out what it means and next steps for access.

Not signed up to receive the latest CF Canada Advocacy news straight to your inbox yet?  

Subscribe to The Advocacy Brief e-newsletter today.